04-29-2020, 12:42 PM
(04-29-2020, 12:02 PM)Goalpost Wrote: So I respect your input Breech. I do differ in the vested interest argument. Most if not all financial analysts are in general agreement that the drug companies will not reap much financial reward for this. In fact Gilead re-opened modestly but the market in general went up much more on the news. And I know you didn't say it as such, but many have vilified drug companies in the past but the reality in this case is the expected profits of a treatment or vaccine compared to the dollars spent in research is but a sliver to their every day business. The cure isn't expected to be much financial rewards to drug companies.
The US government has spent over a billion dollars to stockpile Tamiflu. That's sales to just one customer. For a drug of questionable efficacy. There are billions of dollars at stake for the first company able to market a treatment. Just the rumor of a treatment can affect their stock favorably. That press release by the manufacturer is nothing but marketing hype. It essentially indicates taking Tic Tacs for 5 days has the same out come as taking Tic Tacs for 10 days. Because their study doesn't test their drug against placebo . . . and the manufacturer knows that, but it didn't stop them from making that press release touting a study with highly questionable results. Why?
[video=youtube][/video]